Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

21 results
  1. ... after 24-month followup: death, myocardial infarction, stroke, Class II–IV angina, or sever asymptomatic ischemia ). 85 Also, followup periods ...
  2. ... by preventing angiotensin II from binding to angiotensin II receptors on the muscles ... treat angina, and reduce high blood pressure B-type natriuretic ...
  3. ... Effects of Cardiac Resynchronization Therapy in Patients With Class II vs Class III and IV Heart Failure (From ... effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from ...
  4. ... on their surface called major histocompatibility complex (MHC) class II proteins, which is where the condition got its ... BLS type II</synonym><synonym >Major histocompatibility complex class II deficiency</synonym><synonym >MHC class II deficiency</synonym>< ...
  5. ... 0.75 point each for i) NYHA functional class III/IV; ii) systemic atrioventricular valve regurgitation (moderate/severe); iii) pulmonary ...
  6. ... and decrease blood pressure. Valsartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action ...
  7. ... clinical database to adjust for age, gender, unstable angina, ejection fraction, functional class, shock, preoperative intra-aortic balloon pump, recent myocardial ...
  8. ... a tube made of fabric.</td> </tr> <tr class="r2"> <td><strong><a href="https://medlineplus.gov/angina.html">Angina</a></strong> - chest pain from coronary ...
  9. ... predict psychiatric disorder: prospective results from the Whitehall II Study. Occup Environ Med. 1999; 56 (5):302–7. [ PMC free article : PMC1757742 ] [ PubMed : 10472303 ] 183. Muntaner C, Eaton WW, Diala C, et al. Social class, assets, organizational control and the prevalence of common ...
  10. Type II hyperlipoproteinemia; Hypercholesterolemic xanthomatosis; Low density lipoprotein receptor mutation ... Praluent) and evolocumab (Repatha). These represent a newer class of drugs to treat high cholesterol. People with ...
previous · 1 · 2 · 3 · next